NYSE · Structural Heart & Critical Care Medical Devices · Moderate-liquidity options · Large cap · ~$42B
Edwards Lifesciences is a pure-play structural heart compounder with one of the most defensible market positions in all of medical devices — its SAPIEN TAVR platform holds roughly 50% global market share in a procedure growing 10–15% annually as cardiologists expand indication to lower-risk and younger patients. The total addressable market remains underpenetrated; millions of patients globally with severe aortic stenosis are still being managed conservatively rather than treated. TAVR procedure volumes are driven by aging demographics and guideline expansion — both secular and durable. The company is also expanding into mitral and tricuspid valve therapies, a market with a potentially larger total addressable market than TAVR. Gross margins above 77% and a clear leader-follower competitive dynamic (versus Abbott and Medtronic) make EW a high-quality, high-margin growth compounder.
This page is updated every 72 hours with the latest Scan results. Each data point below represents one complete algorithmic snapshot in time.
Every setup carries risk. Here's what could move EW against you, plus the key stats that frame any position.
Edwards Lifesciences Corporation (EW) currently has an Amora Edge Score of 73/100, ranking it top 28% of today's scan. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.
EW's historical win rate on closed Stoptions setups is 71%. Win rate is calculated as the percentage of past EW trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.
The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.
Every 72 hours we refresh EW's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If EW drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.
The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to EW: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is EW outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. EW currently scores 73.
EW's sector rank and percentile against other Structural Heart & Critical Care Medical Devices tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Structural Heart & Critical Care Medical Devices Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.
Educational content only — not personalized investment advice. Options carry substantial risk.
Every Friday at 4:30 PM ET — Trade of the Week, Signal Movement, Sector Spotlight, Technical Analysis, and more. A 4-minute read. Free.
No spam. One email Friday afternoon. Unsubscribe in one click.